Published in AIDS Weekly, February 21st, 2000
The AC133 is a novel antigen selectively expressed on primitive CD34bright stem cells and is a valuable marker for the selection of long-term culture-initiating cells and severe combined immunodeficiency-repopulating cells. Human placental cord blood (HPCB) is a rich source of CD34+AC133+ cells, noted Y. Li and colleagues.
Li et al. examined the susceptibility of HPCB-isolated CD34+AC133+ stem cells to HIV-1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.